Key result
Transient treatment with losartan in spontaneously hypertensive rats resulted in prolonged blood pressure reduction after withdrawal (153 +/- 5 mmHg vs 184 +/- 3 mmHg for placebo).
Why the study?
Does transient treatment with losartan reduce long-term blood pressure and alter medullary pericyte number in spontaneously hypertensive rats?
Does transient treatment with losartan reduce long-term blood pressure and alter medullary pericyte number in spontaneously hypertensive rats?
Absolute Event Rate: 153% vs 184%
Transient angiotensin II receptor blockade with losartan in young spontaneously hypertensive rats leads to prolonged blood pressure lowering associated with increased medullary blood flow and reduced medullary pericytes.
Early ARB exposure may induce durable BP control in hypertensive rat models; leaves open pericyte mechanisms and human translation.
AIM: Transient angiotensin II receptor blockade (ARB) leads to prolonged blood pressure (BP) lowering, but the underlying mechanism remains uncertain. Long-term BP control is regulated by the medullary microcirculation with the pericyte as contractile cell. We hypothesize that the prolonged BP effect is caused by increased medullary blood flow (MBF) associated with structural alterations based on reduced medullary pericyte number. METHODS: Four-week-old spontaneously hypertensive rats (SHR) were treated for 4 weeks with losartan (SHR-Los: 20 mg kg(-1) day(-1)), hydralazine (SHR-Hyd: 15 mg kg(-1) day(-1)), losartan and pan-caspase inhibitor zVAD (SHR-Los + 1 mg kg(-1) day(-1) zVAD), losartan and glycogen synthase kinase-3beta (GSK) inhibitor valproate (SHR-Los + 10 mg kg(-1) day(-1) Val) or placebo. BP, MBF and pericyte number were determined under and after treatment (8 and 12 weeks). Apoptotic pericytes were determined with alpha-actin and TUNEL double staining. Sodium concentration was determined in renal medulla and urine. RESULTS: Antihypertensive treatment equipotently reduced BP at 8 weeks of age. After drug withdrawal (12 weeks of age) BP reduction was restricted to SHR-Los (SHR-Los: 153 +/- 5, SHR-Hyd: 177 +/- 2, SHR: 184 +/- 3 mmHg). Simultaneously, MBF was increased and pericyte number reduced, while medullary and urinary sodium concentration increased. Transient ARB in combination with zVAD or valproate resulted in more medullary pericytes and higher BP (SHR-Los/zVAD: 164 +/- 7; SHR-Los/Val: 168 +/- 6 mmHg) compared with transient ARB alone. CONCLUSION: After drug withdrawal, transient ARB leads to increased MBF and is associated with a reduction in medullary pericytes. This may be associated with pericyte apoptosis as anti-apoptosis during transient ARB increases pericyte number and BP.
No takes yet. Share an insight, caveat, or question.
Baumann et al. (2008) studied Hypertension. Losartan vs. Placebo, hydralazine, or losartan combinations was evaluated on Blood pressure at 12 weeks of age (after drug withdrawal). Transient treatment with losartan in spontaneously hypertensive rats resulted in prolonged blood pressure reduction after withdrawal (153 +/- 5 mmHg vs 184 +/- 3 mmHg for placebo).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: